Montgomery Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Buy
4,220
+1
+0% +$196 0.27% 57
2026
Q1
$827K Buy
4,219
+1
+0% +$194 0.28% 54
2025
Q4
$732K Sell
4,218
-13
-0.3% -$2.37K 0.26% 53
2025
Q3
$806K Buy
4,231
+1
+0% +$177 0.28% 52
2025
Q2
$760K Hold
4,230
0.29% 49
2025
Q1
$716K Hold
4,230
0.28% 51
2024
Q4
$638K Hold
4,230
0.25% 53
2024
Q3
$657K Hold
4,230
0.24% 49
2024
Q2
$579K Hold
4,230
0.23% 53
2024
Q1
$563K Sell
4,230
-2,200
-34% -$285K 0.21% 52
2023
Q4
$887K Sell
6,430
-300
-4% -$39.4K 0.27% 46
2023
Q3
$820K Hold
6,730
0.28% 46
2023
Q2
$946K Hold
6,730
0.32% 45
2023
Q1
$952K Sell
6,730
-1,300
-16% -$186K 0.34% 43
2022
Q4
$1.26M Sell
8,030
-180
-2% -$25.9K 0.45% 43
2022
Q3
$1.01M Sell
8,210
-30
-0.4% -$3.95K 0.41% 43
2022
Q2
$1.1M Hold
8,240
0.44% 42
2022
Q1
$1.13M Sell
8,240
-700
-8% -$97.6K 0.39% 43
2021
Q4
$1.55M Hold
8,940
0.52% 38
2021
Q3
$1.3M Buy
8,940
+300
+3% +$43.9K 0.48% 38
2021
Q2
$1.14M Sell
8,640
-300
-3% -$39.3K 0.42% 40
2021
Q1
$1.15M Hold
8,940
0.44% 40
2020
Q4
$1.06M Hold
8,940
0.49% 37
2020
Q3
$1.02M Sell
8,940
-340
-4% -$40.2K 0.54% 37
2020
Q2
$1.06M Sell
9,280
-600
-6% -$63.6K 0.57% 38
2020
Q1
$793K Sell
9,880
-1,505
-13% -$156K 0.52% 41
2019
Q4
$1.22M Sell
11,385
-700
-6% -$73K 0.5% 44
2019
Q3
$1.29M Hold
12,085
0.55% 42
2019
Q2
$1.23M Hold
12,085
0.54% 44
2019
Q1
$1.09M Sell
12,085
-300
-2% -$26K 0.48% 47
2018
Q4
$1.03M Sell
12,385
-150
-1% -$14.1K 0.52% 45
2018
Q3
$1.35M Hold
12,535
0.56% 45
2018
Q2
$1.38M Hold
12,535
0.57% 45
2018
Q1
$1.26M Hold
12,535
0.53% 45
2017
Q4
$1.23M Hold
12,535
0.5% 46
2017
Q3
$1.17M Hold
12,535
0.52% 45
2017
Q2
$1.39M Hold
12,535
0.64% 39
2017
Q1
$1.23M Sell
12,535
-600
-5% -$57.2K 0.53% 45
2016
Q4
$1.21M Hold
13,135
0.52% 46
2016
Q3
$1.11M Sell
13,135
-260
-2% -$21.8K 0.52% 46
2016
Q2
$1.09M Sell
13,395
-1,600
-11% -$122K 0.53% 42
2016
Q1
$1.07M Sell
14,995
-200
-1% -$13.4K 0.62% 40
2015
Q4
$1.08M Hold
15,195
0.61% 43
2015
Q3
$934K Hold
15,195
0.55% 44
2015
Q2
$1.1M Buy
15,195
+1,305
+9% +$96.4K 0.56% 44
2015
Q1
$1.07M Sell
13,890
-300
-2% -$21.5K 0.54% 46
2014
Q4
$951K Buy
14,190
+4,120
+41% +$260K 0.45% 50
2014
Q3
$611K Sell
10,070
-680
-6% -$41.9K 0.42% 55
2014
Q2
$631K Sell
10,750
-1,900
-15% -$111K 0.48% 49
2014
Q1
$733K Sell
12,650
-770
-6% -$41.3K 0.6% 44
2013
Q4
$719K Sell
13,420
-12,270
-48% -$728K 0.59% 47
2013
Q3
$1.59M Sell
25,690
-1,300
-5% -$77.8K 0.86% 34
2013
Q2
$1.64M Buy
+26,990
New +$1.61M 0.9% 33

Other funds holding DGX

Montgomery Investment Management's DGX Position: Q2 2026 in Review

Montgomery Investment Management increased its Quest Diagnostics (DGX) stake by 0.02% in Q2 2026, buying an estimated $196 and bringing the position to 4,220 shares worth $895K. The position accounts for 0.27% of the portfolio, ranked #57.

Montgomery Investment Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.64M in Q2 2013. 134 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Montgomery Investment Management held 4,220 shares of Quest Diagnostics worth $895K as of Q2 2026.
  • Montgomery Investment Management bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.27% of Montgomery Investment Management's portfolio in Q2 2026, its #57 holding.
  • Montgomery Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Montgomery Investment Management's Quest Diagnostics position peaked at $1.64M in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Montgomery Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.